Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jan 28, 2018 10:14am
42 Views
Post# 27449434

RE:RE:RE:RE:April 28, 2016 AbbVie Buying Cancer Drug Startup Stemcentrx

RE:RE:RE:RE:April 28, 2016 AbbVie Buying Cancer Drug Startup Stemcentrx Lol shorting the stock, can't go much lower than this!! This is buying time with one nr explosion. So why are we waiting??? Take a hike scumbag! You are loving a pp, lull be hear for another year at least!!! Roger can make everything good with one nr or a great deal! Those really are is only two choices!!! A pp is a luau so why go there when he has been using the last 11 months to get us a great deal, or at worst, a jv!! A FUKKIN PP SHOULD NOT BE IN OUR FUTURE!!!!!!!!!!!!!!!!! NOT WITH TWO OTHER CHOICES AVAILABLE! quote=bionicjoe]Macman1519, you need to shut up trying to make the CEO look like a criminal if he has to resort to a PP.

Unless of course you are prepared to offer RW the $5 million needed to run the company operations for another year? Did I hear you say you don't have the money? Well then why don't you let the man do his job with what he has to work with at the present time.and stop trying to incite the mob by throwing gasoline on an already burning fire with each of your posts. That's the kind of tactics expected from someone heavily shorting the stock. [/quote]

Bullboard Posts